期刊文献+

Glycoconjugation: An approach to cancer therapeutics

Glycoconjugation: An approach to cancer therapeutics
下载PDF
导出
摘要 Cancer constitutes the second leading cause of death globally and is considered to have been responsible for an estimated 9.6 million fatalities in 2018.Although treatments against gastrointestinal tumors have recently advanced,those interventions can only be applied to a minority of patients at the time of diagnosis.Therefore,new therapeutic options are necessary for advanced stages of the disease.Glycosylation of antitumor agents,has been found to improve pharmacokinetic parameters,reduce side effects,and expand drug half-life in comparison with the parent compounds.In addition,glycosylation of therapeutic agents has been proven to be an effective strategy for their targeting tumor tissue,thereby reducing the doses of the glycodrugs administered to patients.This review focusses on the effect of the targeting properties of glycosylated antitumor agents on gastrointestinal tumors. Cancer constitutes the second leading cause of death globally and is considered to have been responsible for an estimated 9.6 million fatalities in 2018. Although treatments against gastrointestinal tumors have recently advanced, those interventions can only be applied to a minority of patients at the time of diagnosis. Therefore, new therapeutic options are necessary for advanced stages of the disease. Glycosylation of antitumor agents, has been found to improve pharmacokinetic parameters, reduce side effects, and expand drug half-life in comparison with the parent compounds. In addition, glycosylation of therapeutic agents has been proven to be an effective strategy for their targeting tumor tissue,thereby reducing the doses of the glycodrugs administered to patients. This review focusses on the effect of the targeting properties of glycosylated antitumor agents on gastrointestinal tumors.
出处 《World Journal of Clinical Oncology》 2020年第3期110-120,共11页 世界临床肿瘤学杂志(英文版)
基金 Supported by the Agencia Nacional de Promoción Científica y Tecnológica,No.ANPCy TPICT2018-02032 RES-2019-401-APN-DANPCYT#ANPCYT(To Molejon MI),No.ANPCy TPICT2017-2070 RES-2017-310/18(To Breccia JD),and No.ANPCy TPICT2016-2258 RES-2017-285-APNDANPCYT#MCT University of Buenos Aires-UBACy T2018,RES(CS)No1041/18(To Vaccaro MI) the National Scientific and Technical Research Council(CONICET) the National University of La Pampa
关键词 GLYCOSYLATION Gastrointestinal cancers Antitumoral agents Therapeutic strategies Drug targeting Glycosylation Gastrointestinal cancers Antitumoral agents Therapeutic strategies Drug targeting
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部